SCHEMBL29599708

SCHEMBL29599708

O=C(O)C1CCCC(O)C1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.43
AKR1C1 Q04828 1/20 0.43
SLC18A3 Q16572 5/20 0.42
FABP7 O15540 3/20 0.42
FABP5 Q01469 3/20 0.42
LMNA P02545 2/20 0.40
RAB9A P51151 1/20 0.40
HDAC4 P56524 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
TACR1 P25103 1/20 0.39
FABP3 P05413 2/20 0.39
HTT P42858 1/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22830852 1.00 AKR1C3 (0.43) AKR1C3AKR1C1SLC18A3FABP7FABP5
SCHEMBL22830919 1.00 AKR1C3 (0.43) AKR1C3AKR1C1SLC18A3FABP7FABP5
SCHEMBL22492144 1.00 AKR1C3 (0.43) AKR1C3AKR1C1SLC18A3FABP7FABP5
SCHEMBL8327892 0.89 AKR1C3 (0.50) AKR1C3AKR1C1FABP7FABP5LMNA
SCHEMBL8327889 0.89 AKR1C3 (0.50) AKR1C3AKR1C1FABP7FABP5LMNA
SCHEMBL28441912 0.79 MAPT (0.51) MAPTHTTCYP2D6CYP1A2TSHR
SCHEMBL9169697 0.76 SLC18A3 (0.41) SLC18A3
SCHEMBL4522521 0.76 KCNQ3 (0.53) AKR1C3AKR1C1FABP7FABP5LMNA
SCHEMBL7352068 0.76 KCNQ3 (0.53) AKR1C3AKR1C1FABP7FABP5LMNA
SCHEMBL7352063 0.76 KCNQ3 (0.53) AKR1C3AKR1C1FABP7FABP5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332472-B2 Substituted piperidines as inhibitors of ubiquitin specific protease 7 LES LABORATOIRES SERVIER (FR) 2022-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332472-B2 Substituted piperidines as inhibitors of ubiquitin specific protease 7 USP7, PSMA7, PSMB7 AKR1C3 3208/4885AKR1C1 3656/4885SLC18A3 4477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.